Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Structural, functional, and behavioral insights of dopamine dysfunction revealed by a deletion in SLC6A3.

Campbell NG, Shekar A, Aguilar JI, Peng D, Navratna V, Yang D, Morley AN, Duran AM, Galli G, O'Grady B, Ramachandran R, Sutcliffe JS, Sitte HH, Erreger K, Meiler J, Stockner T, Bellan LM, Matthies HJG, Gouaux E, Mchaourab HS, Galli A.

Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3853-3862. doi: 10.1073/pnas.1816247116. Epub 2019 Feb 12.

PMID:
30755521
2.

Bile diversion, a bariatric surgery, and bile acid signaling reduce central cocaine reward.

Reddy IA, Smith NK, Erreger K, Ghose D, Saunders C, Foster DJ, Turner B, Poe A, Albaugh VL, McGuinness O, Hackett TA, Grueter BA, Abumrad NN, Flynn CR, Galli A.

PLoS Biol. 2018 Jul 26;16(7):e2006682. doi: 10.1371/journal.pbio.2006682. eCollection 2018 Jul.

3.

Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels.

Reddy IA, Pino JA, Weikop P, Osses N, Sørensen G, Bering T, Valle C, Bluett RJ, Erreger K, Wortwein G, Reyes JG, Graham D, Stanwood GD, Hackett TA, Patel S, Fink-Jensen A, Torres GE, Galli A.

Transl Psychiatry. 2016 May 17;6:e809. doi: 10.1038/tp.2016.86.

4.

mTORC2/rictor signaling disrupts dopamine-dependent behaviors via defects in striatal dopamine neurotransmission.

Dadalko OI, Siuta M, Poe A, Erreger K, Matthies HJ, Niswender K, Galli A.

J Neurosci. 2015 Jun 10;35(23):8843-54. doi: 10.1523/JNEUROSCI.0887-15.2015.

5.

Rare autism-associated variants implicate syntaxin 1 (STX1 R26Q) phosphorylation and the dopamine transporter (hDAT R51W) in dopamine neurotransmission and behaviors.

Cartier E, Hamilton PJ, Belovich AN, Shekar A, Campbell NG, Saunders C, Andreassen TF, Gether U, Veenstra-Vanderweele J, Sutcliffe JS, Ulery-Reynolds PG, Erreger K, Matthies HJ, Galli A.

EBioMedicine. 2015 Feb;2(2):135-146.

6.

Zn(2+) reverses functional deficits in a de novo dopamine transporter variant associated with autism spectrum disorder.

Hamilton PJ, Shekar A, Belovich AN, Christianson NB, Campbell NG, Sutcliffe JS, Galli A, Matthies HJ, Erreger K.

Mol Autism. 2015 Feb 24;6:8. doi: 10.1186/s13229-015-0002-7. eCollection 2015.

7.

SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.

Bowton E, Saunders C, Reddy IA, Campbell NG, Hamilton PJ, Henry LK, Coon H, Sakrikar D, Veenstra-VanderWeele JM, Blakely RD, Sutcliffe J, Matthies HJ, Erreger K, Galli A.

Transl Psychiatry. 2014 Oct 14;4:e464. doi: 10.1038/tp.2014.90.

8.

Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.

Hansen FH, Skjørringe T, Yasmeen S, Arends NV, Sahai MA, Erreger K, Andreassen TF, Holy M, Hamilton PJ, Neergheen V, Karlsborg M, Newman AH, Pope S, Heales SJ, Friberg L, Law I, Pinborg LH, Sitte HH, Loland C, Shi L, Weinstein H, Galli A, Hjermind LE, Møller LB, Gether U.

J Clin Invest. 2014 Jul;124(7):3107-20. doi: 10.1172/JCI73778. Epub 2014 Jun 9.

9.

PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein.

Hamilton PJ, Belovich AN, Khelashvili G, Saunders C, Erreger K, Javitch JA, Sitte HH, Weinstein H, Matthies HJG, Galli A.

Nat Chem Biol. 2014 Jul;10(7):582-589. doi: 10.1038/nchembio.1545. Epub 2014 Jun 1. Erratum in: Biol Psychiatry. 2017 Apr 15;81(8):728.

10.

Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood.

Ng J, Zhen J, Meyer E, Erreger K, Li Y, Kakar N, Ahmad J, Thiele H, Kubisch C, Rider NL, Morton DH, Strauss KA, Puffenberger EG, D'Agnano D, Anikster Y, Carducci C, Hyland K, Rotstein M, Leuzzi V, Borck G, Reith ME, Kurian MA.

Brain. 2014 Apr;137(Pt 4):1107-19. doi: 10.1093/brain/awu022. Epub 2014 Mar 10.

11.

Drosophila melanogaster: a novel animal model for the behavioral characterization of autism-associated mutations in the dopamine transporter gene.

Hamilton PJ, Campbell NG, Sharma S, Erreger K, Hansen FH, Saunders C, Belovich AN, Sahai MA, Cook EH, Gether U, McHaourab HS, Matthies HJ, Sutcliffe JS, Galli A.

Mol Psychiatry. 2013 Dec;18(12):1235. doi: 10.1038/mp.2013.157. No abstract available.

PMID:
24253181
12.

De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder.

Hamilton PJ, Campbell NG, Sharma S, Erreger K, Herborg Hansen F, Saunders C, Belovich AN; NIH ARRA Autism Sequencing Consortium, Sahai MA, Cook EH, Gether U, McHaourab HS, Matthies HJ, Sutcliffe JS, Galli A.

Mol Psychiatry. 2013 Dec;18(12):1315-23. doi: 10.1038/mp.2013.102. Epub 2013 Aug 27.

13.

Structural arrangement of the intracellular Ca2+ binding domains of the cardiac Na+/Ca2+ exchanger (NCX1.1): effects of Ca2+ binding.

Dixit M, Kim S, Matthews GF, Erreger K, Galli A, Cobb CE, Hustedt EJ, Beth AH.

J Biol Chem. 2013 Feb 8;288(6):4194-207. doi: 10.1074/jbc.M112.423293. Epub 2012 Dec 11.

14.

GLP-1 analog attenuates cocaine reward.

Graham DL, Erreger K, Galli A, Stanwood GD.

Mol Psychiatry. 2013 Sep;18(9):961-2. doi: 10.1038/mp.2012.141. Epub 2012 Oct 23. No abstract available.

15.

Exendin-4 decreases amphetamine-induced locomotor activity.

Erreger K, Davis AR, Poe AM, Greig NH, Stanwood GD, Galli A.

Physiol Behav. 2012 Jun 25;106(4):574-8. doi: 10.1016/j.physbeh.2012.03.014. Epub 2012 Mar 19.

16.

Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder.

Bowton E, Saunders C, Erreger K, Sakrikar D, Matthies HJ, Sen N, Jessen T, Colbran RJ, Caron MG, Javitch JA, Blakely RD, Galli A.

J Neurosci. 2010 Apr 28;30(17):6048-57. doi: 10.1523/JNEUROSCI.5094-09.2010.

17.

Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.

Binda F, Dipace C, Bowton E, Robertson SD, Lute BJ, Fog JU, Zhang M, Sen N, Colbran RJ, Gnegy ME, Gether U, Javitch JA, Erreger K, Galli A.

Mol Pharmacol. 2008 Oct;74(4):1101-8. doi: 10.1124/mol.108.048447. Epub 2008 Jul 10.

18.

Currents in response to rapid concentration jumps of amphetamine uncover novel aspects of human dopamine transporter function.

Erreger K, Grewer C, Javitch JA, Galli A.

J Neurosci. 2008 Jan 23;28(4):976-89. doi: 10.1523/JNEUROSCI.2796-07.2008.

19.

Zinc inhibition of rat NR1/NR2A N-methyl-D-aspartate receptors.

Erreger K, Traynelis SF.

J Physiol. 2008 Feb 1;586(3):763-78. Epub 2007 Nov 29.

20.

Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes.

Chen PE, Geballe MT, Katz E, Erreger K, Livesey MR, O'Toole KK, Le P, Lee CJ, Snyder JP, Traynelis SF, Wyllie DJ.

J Physiol. 2008 Jan 1;586(1):227-45. Epub 2007 Oct 25.

21.

Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors.

Erreger K, Geballe MT, Kristensen A, Chen PE, Hansen KB, Lee CJ, Yuan H, Le P, Lyuboslavsky PN, Micale N, Jørgensen L, Clausen RP, Wyllie DJ, Snyder JP, Traynelis SF.

Mol Pharmacol. 2007 Oct;72(4):907-20. Epub 2007 Jul 10.

PMID:
17622578
22.

Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block.

Dravid SM, Erreger K, Yuan H, Nicholson K, Le P, Lyuboslavsky P, Almonte A, Murray E, Mosely C, Barber J, French A, Balster R, Murray TF, Traynelis SF.

J Physiol. 2007 May 15;581(Pt 1):107-28. Epub 2007 Feb 15.

23.
24.

Mechanism of partial agonism at NMDA receptors for a conformationally restricted glutamate analog.

Erreger K, Geballe MT, Dravid SM, Snyder JP, Wyllie DJ, Traynelis SF.

J Neurosci. 2005 Aug 24;25(34):7858-66.

25.

Conserved structural and functional control of N-methyl-D-aspartate receptor gating by transmembrane domain M3.

Yuan H, Erreger K, Dravid SM, Traynelis SF.

J Biol Chem. 2005 Aug 19;280(33):29708-16. Epub 2005 Jun 21.

26.

Glutamate receptor gating.

Erreger K, Chen PE, Wyllie DJ, Traynelis SF.

Crit Rev Neurobiol. 2004;16(3):187-224. Review.

PMID:
15701057
27.

Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles.

Erreger K, Dravid SM, Banke TG, Wyllie DJ, Traynelis SF.

J Physiol. 2005 Mar 1;563(Pt 2):345-58. Epub 2005 Jan 13.

28.

Open probability of homomeric murine 5-HT3A serotonin receptors depends on subunit occupancy.

Mott DD, Erreger K, Banke TG, Traynelis SF.

J Physiol. 2001 Sep 1;535(Pt 2):427-43.

29.

Allosteric interaction between the amino terminal domain and the ligand binding domain of NR2A.

Zheng F, Erreger K, Low CM, Banke T, Lee CJ, Conn PJ, Traynelis SF.

Nat Neurosci. 2001 Sep;4(9):894-901.

PMID:
11528420

Supplemental Content

Loading ...
Support Center